Intercept Pharmaceuticals CEO Jerome Durso's 2021 pay jumps 101% to $7.9M
Intercept Pharmaceuticals reports 2021 executive compensation
By ExecPay News
Published: May 2, 2022
Intercept Pharmaceuticals reported fiscal year 2021 executive compensation information on May 2, 2022.
In 2021, seven executives at Intercept Pharmaceuticals received on average a compensation package of $3.2M, a 5% increase compared to previous year.
Average pay of disclosed executives at Intercept Pharmaceuticals
Jerome Durso, Chief Executive Officer, received $7.9M in total, which increased by 101% compared to 2020. 70% of Durso's compensation, or $5.5M, was in stock awards. Durso also received $436K in non-equity incentive plan, $1.2M in option awards, $691K in salary, as well as $34K in other compensation.
For fiscal year 2021, the median employee pay was $216,748 at Intercept Pharmaceuticals. Therefore, the ratio of Jerome Durso's pay to the median employee pay was 36 to one.
Jared Freedberg, General Counsel, received a compensation package of $3.8M. 43% of the compensation package, or $1.6M, was in stock awards.
Michelle Berrey, Chief Medical Officer, earned $3.1M in 2021.
Gail Cawkwell, SVP Medical Affairs, Safety & Pharmacovigilance, received $2.6M in 2021.
Andrew Saik, Chief Financial Officer, earned $2.5M in 2021.
Sandip Kapadia, Chief Financial Officer, received $1.7M in 2021, which decreases by 28% compared to 2020.
Rocco Venezia, Chief Financial Officer, earned $856K in 2021.
Related executives
Jerome Durso
Intercept Pharmaceuticals
Chief Executive Officer
Andrew Saik
Intercept Pharmaceuticals
Chief Financial Officer
Sandip Kapadia
Intercept Pharmaceuticals
Chief Financial Officer
Rocco Venezia
Intercept Pharmaceuticals
Chief Financial Officer
Jared Freedberg
Intercept Pharmaceuticals
General Counsel
Michelle Berrey
Intercept Pharmaceuticals
Chief Medical Officer
Gail Cawkwell
Intercept Pharmaceuticals
SVP Medical Affairs, Safety & Pharmacovigilance
You may also like
Source: SEC filing on May 2, 2022.